TABLE 2

Outcomes of Treatment With Buprenorphine and NOS

ParameterBuprenorphineNOSPa
n1213
Length of treatment, d2232.077
Length of stay, d2738.068
  • Data from the patient who was withdrawn from treatment because of seizure is not included; this infant had a length of stay of 28 days.

  • a Wilcoxon rank-sum test.